Point72 Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31M | Buy |
+2,213,947
| New | +$31M | 0.06% | 315 |
|
|
2025
Q1 | – | Sell |
-548,739
| Closed | -$11.2M | – | 1399 |
|
|
2024
Q4 | $11.2M | Buy |
548,739
+215,209
| +65% | +$4.39M | 0.02% | 517 |
|
|
2024
Q3 | $9.72M | Sell |
333,530
-719,620
| -68% | -$21M | 0.02% | 508 |
|
|
2024
Q2 | $24.5M | Buy |
+1,053,150
| New | +$24.5M | 0.06% | 321 |
|
|
2024
Q1 | – | Sell |
-644,406
| Closed | -$13.8M | – | 1540 |
|
|
2023
Q4 | $13.8M | Buy |
+644,406
| New | +$13.8M | 0.03% | 490 |
|
|
2023
Q3 | – | Sell |
-223,471
| Closed | -$6.59M | – | 1852 |
|
|
2023
Q2 | $6.59M | Buy |
+223,471
| New | +$6.59M | 0.02% | 614 |
|
|
2023
Q1 | – | Sell |
-64,400
| Closed | -$1.79M | – | 1752 |
|
|
2022
Q4 | $1.79M | Sell |
64,400
-568,600
| -90% | -$15.8M | 0.01% | 771 |
|
|
2022
Q3 | $19.4M | Buy |
+633,000
| New | +$19.4M | 0.08% | 310 |
|